Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

PharmaEssentia Corporation (TWO: 6446)

 
6446 Technical Analysis
5
As on 26th Mar 2024 6446 STOCK Price closed @ 318.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 429.80 & Strong Sell for SHORT-TERM with Stoploss of 501.64 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

6446STOCK Price

Open 328.00 Change Price %
High 328.00 1 Day -7.50 -2.30
Low 316.00 1 Week -8.50 -2.60
Close 318.00 1 Month 4.00 1.27
Volume 1354347 1 Year -258.00 -44.79
52 Week High 591.00 | 52 Week Low 283.00
 
TWO Taiwan Most Active Stocks
1815 90.70 %
6265 33.45 %
8358 290.00 %
3264 126.50 %
3624 64.20 %
5351 55.80 %
4979 327.50 %
6173 70.30 %
6127 37.50 %
3236 30.10 %
 
TWO Taiwan Top Gainers Stocks
5306 172.00 3.30%
8923 20.00 2.56%
8923 20.00 2.56%
8438 38.40 1.99%
6457 62.10 1.47%
6589 66.40 0.45%
6472 645.00 0.31%
1752 39.55 0.25%
1752 39.55 0.25%
 
TWO Taiwan Top Losers Stocks
3202 3.96 -10.00%
6446 318.00 -2.30%
6423 96.50 -1.03%
8420 40.60 -0.98%
8420 40.60 -0.98%
3652 22.55 -0.88%
4736 156.50 -0.32%
 
 
6446
Daily Charts		 6446
Intraday Charts		 Whats New @
Bazaartrend		 6446
Free Analysis
 
6446 Important Levels Intraday
RESISTANCE341.12
RESISTANCE333.71
RESISTANCE329.12
RESISTANCE324.54
SUPPORT311.46
SUPPORT306.88
SUPPORT302.29
SUPPORT294.88
 
6446 Forecast January 2026
Share
4th UP Forecast568.51
3rd UP Forecast488.17
2nd UP Forecast438.51
1st UP Forecast388.85
1st DOWN Forecast247.15
2nd DOWN Forecast197.49
3rd DOWN Forecast147.83
4th DOWN Forecast67.49
 
6446 Weekly Forecast
4th UP Forecast510.70
3rd UP Forecast448.90
2nd UP Forecast410.70
1st UP Forecast372.50
1st DOWN Forecast263.50
2nd DOWN Forecast225.30
3rd DOWN Forecast187.10
4th DOWN Forecast125.30
 
6446 Forecast2026
4th UP Forecast942.35
3rd UP Forecast742.12
2nd UP Forecast618.35
1st UP Forecast494.58
1st DOWN Forecast141.42
2nd DOWN Forecast17.65
3rd DOWN Forecast-106.12
4th DOWN Forecast-306.35
 
 
6446 Other Details
Segment EQ
Market Capital 25268811776.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
6446 Address
6446
 
6446 Latest News
 
Your Comments and Response on PharmaEssentia Corporation
 
6446 Business Profile
PharmaEssentia Corporation engages in the research, development, production, and sale of therapeutic products for the treatment of human diseases. Its products include ropeginterferon alfa-2b that is used for the treatment of polycythemia vera, essential thrombocythemia, and hepatitis B and C; and Anti-PD-1 antibody for the treatment of cancer. The company also licensed to develop Oraxol for the treatment of breast, advanced gastric, and esophageal cancer; KX01 for the treatment of psoriasis and actinic keratosis. It also focuses on the drug research and development programs in the areas of hematology, infectious disease, oncology, and dermatology. The company has a research collaboration agreement with Axis Therapeutics Limite for the development of T Cell Receptor-T therapy based on the T cell receptor affinity enhancing specific T cell therapy technology platform. PharmaEssentia Corporation was founded in 2003 and is headquartered in Taipei, Taiwan. Address:
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service